Los Angeles Capital Management LLC Purchases 515,644 Shares of Colgate-Palmolive (NYSE:CL)

Los Angeles Capital Management LLC grew its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 235.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 734,706 shares of the company's stock after purchasing an additional 515,644 shares during the period. Los Angeles Capital Management LLC owned approximately 0.09% of Colgate-Palmolive worth $76,270,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Crossmark Global Holdings Inc. increased its position in shares of Colgate-Palmolive by 138.0% in the third quarter. Crossmark Global Holdings Inc. now owns 166,726 shares of the company's stock worth $17,308,000 after purchasing an additional 96,680 shares during the last quarter. Baker Avenue Asset Management LP increased its holdings in shares of Colgate-Palmolive by 10.9% in the 3rd quarter. Baker Avenue Asset Management LP now owns 4,958 shares of the company's stock worth $515,000 after buying an additional 487 shares during the last quarter. Sustainable Insight Capital Management LLC raised its position in shares of Colgate-Palmolive by 104.8% during the 3rd quarter. Sustainable Insight Capital Management LLC now owns 12,900 shares of the company's stock valued at $1,339,000 after buying an additional 6,600 shares in the last quarter. Essex Savings Bank lifted its holdings in shares of Colgate-Palmolive by 28.6% during the 3rd quarter. Essex Savings Bank now owns 16,618 shares of the company's stock worth $1,725,000 after acquiring an additional 3,694 shares during the last quarter. Finally, SpiderRock Advisors LLC grew its position in Colgate-Palmolive by 1.2% in the third quarter. SpiderRock Advisors LLC now owns 36,749 shares of the company's stock worth $3,815,000 after acquiring an additional 437 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the company's stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company's stock, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have weighed in on CL shares. Evercore ISI raised their price target on Colgate-Palmolive from $100.00 to $106.00 and gave the company an "outperform" rating in a research report on Thursday, July 18th. UBS Group boosted their target price on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a "buy" rating in a research report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and increased their price target for the company from $107.00 to $109.00 in a research report on Monday, September 9th. Piper Sandler assumed coverage on shares of Colgate-Palmolive in a report on Tuesday, September 24th. They issued an "overweight" rating and a $121.00 price objective for the company. Finally, Sanford C. Bernstein upped their price objective on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the company a "market perform" rating in a research note on Tuesday, July 30th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $105.11.

Colgate-Palmolive Trading Up 2.0 %

Shares of Colgate-Palmolive stock traded up $1.80 during midday trading on Friday, reaching $92.57. 4,568,042 shares of the company's stock traded hands, compared to its average volume of 4,630,135. The company has a market cap of $75.63 billion, a PE ratio of 26.52, a price-to-earnings-growth ratio of 3.22 and a beta of 0.42. The stock has a 50 day moving average of $100.91 and a 200-day moving average of $98.44. Colgate-Palmolive has a 12 month low of $74.67 and a 12 month high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.16%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.